<DOC>
	<DOCNO>NCT01680757</DOCNO>
	<brief_summary>This study prospective , multicenter , non‐randomized trial stand‐alone procedure leave atrial appendage exclusion patient atrial fibrillation risk embolic event contraindicate intolerant oral anticoagulation therapy . This study enroll 100 participant , receive LAA ligation study treatment . The objective registry ass effectiveness permanent exclusion LAA use LARIAT Suture Delivery Device Accessories patient unable treated standard anticoagulation therapy . The result study used ass outcome within first year , post‐treatment .</brief_summary>
	<brief_title>Study Left Atrial Appendage Closure Patients With Atrial Fibrillation - III</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>1 . Aged ≥ 21 year 2 . Diagnosed nonvalvular atrial fibrillation 3 . Current CHADS2 score &gt; 2 4 . Currently contraindicate intolerant standard anticoagulation therapy ( i.e. , warfarin , dabigatran , apixaban , rivaroxaban ) due least one following : history bleed high risk bleeding ; labile INR level ( While anticoagulation therapy , participant INR result `` therapeutic range '' &gt; 40 % time , minimum period 2 month . ) ; noncompliant , unwilling take , anticoagulant failure ( e.g. , TIA stroke anticoagulant therapy ) . 5 . Life expectancy least 1 year 6 . Willing able return comply schedule follow visit 7 . Willing able provide write informed consent 1 . Prior cardiac surgery involve open pericardium ( e.g. , CABG , heart transplantation , valve surgery ) 2 . Prosthetic heart valve ring position 3 . Current NYHA Class IV heart failure symptoms 4 . Current right heart failure 5 . Myocardial infarction within last 3 month 6 . Unstable angina within last 3 month 7 . Current cardiogenic shock hemodynamic instability 8 . Current symptomatic carotid disease 9 . Need intraaortic balloon pump intravenous inotropes 10 . Embolic stroke within last 30 day 11 . Transient ischemic attack ( TIA ) within last 30 day 12 . Current diagnosis active systemic infection 13. eGFR &lt; 60 mL/min/1.73m2 within last 3 month 14 . Current renal failure require dialysis 15 . ALT AST level &gt; 3 time upper level normal , indicate hepatic failure . ( NOTE : normal range provide local laboratory perform measurement ) , base recent preprocedure assessment ( within 30 day study treatment ) 16 . Current clinical evidence cirrhosis 17 . Any history thoracic radiation 18 . Current use long term treatment steroid , include intermittent use inhale steroid respiratory diseases 19 . Diagnosed autoimmune disease know associate pericarditis ( i.e. , specific connective tissue disorder ) 20 . Any history pericarditis 21 . Pectus excavatum ( clinically define treat physician ) 22 . Severe scoliosis 23 . Thrombocytopenia ( platelet count &lt; 100 x 109/L ) base recent preprocedure assessment ( within 30 day study treatment ) 24 . Anemia hemoglobin concentration &lt; 10 g/dL base recent preprocedure assessment ( within 30 day study treatment ) 25 . Pregnancy desire get pregnant within next 12 month . 26 . Current enrollment investigation study cardiovascular device investigational drug would interfere registry 27 . Mental impairment condition , may allow patient understand nature , significance scope study 28 . Any criterion , would make patient unsuitable participate study determine clinical site Principal Investigator ( e.g. , uncontrolled drug and/or alcohol addiction )</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Left Atrial Appendage</keyword>
	<keyword>LARIAT</keyword>
	<keyword>atrial fibrillation</keyword>
	<keyword>contraindication oral anticoagulation therapy</keyword>
</DOC>